Jason Zemansky
Stock Analyst at Bank of America Securities
(4.82)
# 468
Out of 4,994 analysts
454
Total ratings
58%
Success rate
21.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jason Zemansky
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LGND Ligand Pharmaceuticals | Maintained: Buy | $388 | $290.07 | +33.76% | 11 | Sep 23, 2026 | |
| INSM Insmed | Maintained: Buy | $214 | $121.00 | +76.86% | 52 | Sep 22, 2026 | |
| ABOS Acumen Pharmaceuticals | Reiterated: Buy | $8 | $2.59 | +208.88% | 14 | Sep 17, 2026 | |
| RCKT Rocket Pharmaceuticals | Reiterated: Buy | $10 | $3.27 | +205.81% | 20 | Sep 15, 2026 | |
| TYRA Tyra Biosciences | Reiterated: Buy | $39 | $25.65 | +52.05% | 17 | Sep 8, 2026 | |
| CYTK Cytokinetics | Reiterated: Hold | $85 | $67.56 | +25.81% | 50 | Aug 31, 2026 | |
| KURA Kura Oncology | Reiterated: Buy | $30 → $31 | $11.60 | +167.24% | 41 | Aug 13, 2026 | |
| BBIO BridgeBio Pharma | Reiterated: Buy | $101 → $104 | $66.58 | +56.20% | 37 | Aug 11, 2026 | |
| KROS Keros Therapeutics | Reiterated: Hold | $20 → $17 | $11.48 | +48.08% | 17 | Aug 11, 2026 | |
| LYEL Lyell Immunopharma | Reiterated: Sell | $12 | $10.93 | +9.79% | 12 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $29 | $25.95 | +11.75% | 38 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 → $26 | $18.07 | +43.88% | 35 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $64 → $71 | $62.86 | +12.95% | 30 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $553 → $543 | $521.96 | +4.03% | 27 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $215 → $219 | $219.07 | -0.03% | 15 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $2.20 | +172.73% | 5 | Jul 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 → $32 | $8.83 | +262.40% | 3 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $0.98 | +614.29% | 19 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $64.06 | n/a | 2 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $15 → $12 | $3.06 | n/a | 4 | Mar 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $1 | $3.25 | n/a | 3 | Dec 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $10.47 | n/a | 2 | Nov 17, 2023 |
Ligand Pharmaceuticals
Sep 23, 2026
Maintained: Buy
Price Target: $388
Current: $290.07
Upside: +33.76%
Insmed
Sep 22, 2026
Maintained: Buy
Price Target: $214
Current: $121.00
Upside: +76.86%
Acumen Pharmaceuticals
Sep 17, 2026
Reiterated: Buy
Price Target: $8
Current: $2.59
Upside: +208.88%
Rocket Pharmaceuticals
Sep 15, 2026
Reiterated: Buy
Price Target: $10
Current: $3.27
Upside: +205.81%
Tyra Biosciences
Sep 8, 2026
Reiterated: Buy
Price Target: $39
Current: $25.65
Upside: +52.05%
Cytokinetics
Aug 31, 2026
Reiterated: Hold
Price Target: $85
Current: $67.56
Upside: +25.81%
Kura Oncology
Aug 13, 2026
Reiterated: Buy
Price Target: $30 → $31
Current: $11.60
Upside: +167.24%
BridgeBio Pharma
Aug 11, 2026
Reiterated: Buy
Price Target: $101 → $104
Current: $66.58
Upside: +56.20%
Keros Therapeutics
Aug 11, 2026
Reiterated: Hold
Price Target: $20 → $17
Current: $11.48
Upside: +48.08%
Lyell Immunopharma
Aug 11, 2026
Reiterated: Sell
Price Target: $12
Current: $10.93
Upside: +9.79%
Aug 11, 2026
Reiterated: Hold
Price Target: $29
Current: $25.95
Upside: +11.75%
Aug 5, 2026
Reiterated: Buy
Price Target: $29 → $26
Current: $18.07
Upside: +43.88%
Aug 5, 2026
Reiterated: Buy
Price Target: $64 → $71
Current: $62.86
Upside: +12.95%
Jul 30, 2026
Reiterated: Hold
Price Target: $553 → $543
Current: $521.96
Upside: +4.03%
Jul 29, 2026
Reiterated: Hold
Price Target: $215 → $219
Current: $219.07
Upside: -0.03%
Jul 27, 2026
Reiterated: Buy
Price Target: $6
Current: $2.20
Upside: +172.73%
Jun 3, 2026
Reiterated: Buy
Price Target: $34 → $32
Current: $8.83
Upside: +262.40%
Feb 17, 2026
Reiterated: Buy
Price Target: $7
Current: $0.98
Upside: +614.29%
Oct 30, 2024
Reiterated: Buy
Price Target: n/a
Current: $64.06
Upside: n/a
Mar 28, 2024
Reiterated: Sell
Price Target: $15 → $12
Current: $3.06
Upside: n/a
Dec 26, 2023
Reiterated: Sell
Price Target: $1
Current: $3.25
Upside: n/a
Nov 17, 2023
Rated: Hold
Price Target: n/a
Current: $10.47
Upside: n/a